Skip to content

Development of the practical usage based technology using the patient customized bioprinting trachea for the regeneration of respiratory tract

Development of the practical usage based technology using the patient customized bioprinting trachea for the regeneration of respiratory tract (trachea)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006399
Enrollment
1
Registered
2021-07-29
Start date
2021-07-31
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(3D cell printing) : Patients who require partial or segment resection of trachea due to thyroid or airway disease voluntarily obtain written consent, conduct a screening test to determine wheth

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who requires partial or segmental resection of trachea for the treatment of trachea diseases such as congenital tracheomalacia and traumatic tracheal stenosis, or invading the trachea due to the progression of thyroid cancer. Patients who are expected to have functional disorders such as respiratory failure or permanent tracheostomy due to the impossibility of reconstruction of the trachea defect.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women 2. Those who have had surgery around the thyroid gland or airway before screening 3. Patients with residual inflammation in the tissues around the thyroid gland or airways at the time of screening 4. Patients with systemic inflammatory disease at the time of screening 5. People at high risk of general anesthesia due to liver disease, kidney disease, or heart disease 6. Patients with sepsis at the time of screening 7. Patients with a predisposition to bleeding at the time of screening 8. Those who have had radiation treatment to the head/neck area before screening 9. Those who have used other clinical trial drugs and clinical trial medical devices within 3 months before screening 10. Patients with a history of cell therapy 11. Patients with malignant tumors other than thyroid cancer 12. Persons judged by other investigators as inappropriate to participate in this clinical trial

Design outcomes

Primary

MeasureTime frame
Flexible laryngoscopy

Countries

Korea, Republic of

Contacts

Public ContactSung Won Kim

The Catholic University of Korea, Seoul St. Mary's Hospital

kswent@catholic.ac.kr+82-2-2258-2866

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026